Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual | Zendy

Solen Kernéis | Zendy; Delphine Planas | Zendy; Sandrine Imbeaud | Zendy; Isabelle Staropoli | Zendy; Julien Puech | Zendy; Nicolas Robillard | Zendy; Julien Rodary | Zendy; Timothée Bruel | Zendy; Thomas Vieillard | Zendy; Olivier Schwartz | Zendy; Laurent Bélec | Zendy; Hélène Péré | Zendy; David Veyer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

Author(s) -

Solen Kernéis,

Delphine Planas,

Sandrine Imbeaud,

Isabelle Staropoli,

Julien Puech,

Nicolas Robillard,

Julien Rodary,

Timothée Bruel,

Thomas Vieillard,

Olivier Schwartz,

Laurent Bélec,

Hélène Péré,

David Veyer

Publication year - 2021

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofab369

Subject(s) - medicine , covid-19 , transmission (telecommunications) , seroconversion , vaccination , virology , alpha (finance) , virus , computer science , outbreak , telecommunications , patient satisfaction , construct validity , nursing , disease , infectious disease (medical specialty)

Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research